Skip to main content
logo
Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
37.82
-2.36 (-5.87%)
At close: Jul 28, 2026, 4:00 PM EDT
37.82
0.00 (0.00%)
After-hours: Jul 28, 2026, 4:10 PM EDT

Nanobiotix Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
32.5932.59-7.1936.214.782.65
Revenue Growth
220.83%--658.12%80.43%5.37%
Gross Profit
32.5932.59-7.1936.214.782.65
Operating Income
-10.82-10.82-68.39-26.78-46.7-52.58
Net Income
-23.96-23.96-68.13-39.7-57.04-47
Earnings Per Share
-0.50-0.50-1.44-1.08-1.64-1.35
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
52.7552.7549.7475.2841.3983.92
Total Debt
95.3295.3250.950.5753.1746.02
Net Cash (Debt)
-42.57-42.57-1.1724.72-11.7837.9
Net Cash Growth
------45.99%
Net Cash Per Share
-0.89-0.89-0.020.67-0.341.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-33.42-33.42-19.55-12.48-37.1-29.87
Capital Expenditures
-0.54-0.54-0.85-0.33-0.09-0.23
Free Cash Flow
-33.96-33.96-20.4-12.8-37.2-30.1
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-33.19%-33.19%951.21%-73.96%-977.85%-1986.36%
Pretax Margin
-73.51%-73.51%946.19%-109.31%-1194.14%-1775.56%
Profit Margin
-73.52%-73.52%947.59%-109.64%-1194.35%-1775.75%
FCF Margin
-104.19%-104.19%283.69%-35.36%-778.79%-1137.14%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
49.5929.27-18.198.5724.9893.72